Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
₹ 256000 / 2000 Shares Shares
Minimum Investment
Curis Lifesciences Limited IPO
Issues Price
₹120-128 per equity share
Curis Lifesciences Limited IPO
Open Date
07 Nov 2025
Close Date
11 Nov 2025
Lot Size
1000
Min. Investment
₹ 256000
Issue Price
₹120-128
Listing Date
14 Nov 2025
Issues Size
21,50,000 shares(aggregating up to ₹27.52 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
2000 Shares
Offered To Public
2000 Shares
Curis Lifesciences Limited IPO
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
Founded In
2020
Managing Director
Dharmesh Dasharathbhai Patel
Parent Organization
Curis Lifesciences Limited IPO
Application for Curis Lifesciences Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹120-128 | ₹2,56,000 |
| Individual(max) | ₹120-128 | ₹2,56,000 |
| SHNI(min) | ₹120-128 | ₹3,84,000 |
| SHNI(max) | ₹120-128 | ₹8,96,000 |
| BHNI(min) | ₹120-128 | ₹10,24,000 |
Apply for all eligible candidates, Curis Lifesciences Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
KSquare simplified wealth creation for me. Instead of random investments, I now follow a clear long-term strategy that actually grows. Their disciplined guidance gives consistent financial confidence every month.
KSquare’s mutual fund platform is exactly what I needed. It’s intuitive, offers diverse funds, and gives great insights. I’ve seen real growth since I started.
I highly recommend KSquare for any NRI investor. Their support was proactive and always ensured I felt secure with every transaction.
KSquare makes it simple to understand which NFO suits you. Their comparisons and insights saved me hours of research. Totally recommend it!
Investing in NFOs through KSquare has been a game changer. Their platform simplifies complex information and provides well-timed suggestions that fit my portfolio.
I love how KSquare offers mutual fund plans that match my income flow and future goals. They’ve made saving and investing seamless for me.
I never thought NPS could be this simple. KSquare gave me full control and transparency over my retirement planning.
KSquare made my NPS journey easy. Their guidance and clear comparison of schemes helped me confidently plan for retirement. I highly recommend their personalized pension support.
I never thought mutual fund investing could be this simple. KSquare helps me manage risk and meet financial targets effortlessly. Great for working women like me.
I’m impressed by how easy KSquare made mutual fund investing. Their platform is clean, quick, and their support staff is always ready to help.
FAQ's
Frequenlty Asked Question
How does a SIP work with KSquare?
With KSquare, you can automate monthly investments into mutual funds, allowing your money to grow with market performance and compounding.
Are mutual funds taxable in India?
Yes, mutual funds are subject to capital gains tax. Taxation depends on the type of fund and holding period.
How are NPS returns calculated?
NPS returns depend on the performance of the equity, corporate debt, and government bond funds you select within your portfolio.
Can I change my fund manager in NPS via KSquare?
Yes, KSquare allows you to switch your fund manager or investment option once a year through your dashboard.
Does KSquare assist with KYC for NRI clients?
Yes, KSquare helps NRIs complete the KYC process digitally, making onboarding quick and hassle-free.
Can I invest in mutual funds online through KSquare?
Yes, KSquare’s digital platform allows you to browse, select, and invest in mutual funds entirely online.
Are mutual funds safe to invest in?
Mutual funds carry market risk, but diversification and professional management help reduce volatility and improve long-term growth potential.
Can I use LAMF for personal or business purposes?
Yes, the loan can be used for any legal personal or business need such as emergencies, education, or working capital.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.